JOURNAL OF THE CZECH PEDIATRIC SOCIETY AND THE SLOVAK PEDIATRIC SOCIETY

Čes-slov Pediat 2022, 77(1):34-38 | DOI: 10.55095/CSPediatrie2022/005

Differential diagnosis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2Short News

Jan David, Jan Lebl
Pediatrická klinika 2. lékařské fakulty a Fakultní nemocnice v Motole

Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) is already becoming known to the Czech paediatric specialist public and is part of a differential diagnosis in patients with a minimum of three days' fever. The presented article is based on recent published studies, but also on the experience of our department and is dedicated to differential diagnosis of this new disease.

Keywords: covid-19, PIMS-TS, děti

Published: January 21, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
David J, Lebl J. Differential diagnosis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Ces-slov Pediat. 2022;77(1):34-38. doi: 10.55095/CSPediatrie2022/005.
Download citation

References

  1. Davies P, Evans C, Kanthimathinathan HK, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health 2020; 4(9): 669-677. Go to original source... Go to PubMed...
  2. Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med 2020; 383(4): 334-346. Go to original source... Go to PubMed...
  3. World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19.(Internet) Dostupné na: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.
  4. Feldstein LR, Tenforde MW, Friedman KG, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA 2021; 325(11): 1074-1087. Go to original source... Go to PubMed...
  5. David J, Šibíková M, Jonáš J, et al. Závažná komplikace COVID-19 u dětí: syndrom multisystémové zánětlivé odpovědi. Pediatr Praxi 2021; 22(1): 8-11. Go to original source...
  6. Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 2020; 369: m2094. Go to original source... Go to PubMed...
  7. Rostad CA, Chahroudi A, Mantus G, et al. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C). Pediatrics 2020; 146(6): e2020018242. Go to original source... Go to PubMed...
  8. Yeo WS, Ng QX. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2. Med Hypotheses 2020; 144: 110263. Go to original source... Go to PubMed...
  9. Fencl F, Šibíková M, David J, Malcová H. Syndrom multisystémové zánětlivé odpovědi asociovaný s COVID-19 u dětí. Doporučený postup. Ces Slov Pediatr 2021; 76(1): 4-9.
  10. Aghagoli G, Gallo Marin B, Katchur NJ, et al. Neurological Involvement in COVID-19 and Potential Mechanisms: A Review. Neurocrit Care 2021; 34(3): 1062-1071. Go to original source... Go to PubMed...
  11. Lad SS, Kait SP, Suryawanshi PB, et al. Neurological Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS). Indian J Pediatr 2021; 88(3): 294-295. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.